Received: from nahou-mscnx06p.corp.enron.com ([192.168.110.237]) by nahou-msmbx01v.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Wed, 30 Jan 2002 22:40:12 -0800
Received: from NAHOU-MSMSW05P.corp.enron.com ([192.168.110.226]) by nahou-mscnx06p.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Thu, 31 Jan 2002 00:38:53 -0600
Received: from mailman.enron.com (unverified) by NAHOU-MSMSW05P.corp.enron.com
 (Content Technologies SMTPRS 4.2.5) with ESMTP id <T5a0a435507c0a86ee241c@NAHOU-MSMSW05P.corp.enron.com> for <tstaab@exchange.enron.com>;
 Thu, 31 Jan 2002 00:37:19 -0600
Received: from d219117028022.cable.ogaki-tv.ne.jp (d219117028022.cable.ogaki-tv.ne.jp [219.117.28.22])
        by mailman.enron.com (8.11.4/8.11.4/corp-1.06) with ESMTP id g343Bbl39412
        for <Theresa.Staab@ENRON.com>; Thu, 31 Jan 2002 00:35:24 -0600 (CST)
Received: from mail pickup service by baneberry.aerostudies.com with Microsoft
 SMTPSVC; Thu, 31 Jan 2002 03:44:20 -0400
Date: Thu, 31 Jan 2002 01:43:20 -0600
From: "Stephan Golden" <jzdsvut@aurorachamber.org>
To: <Theresa.Staab@ENRON.com>
Subject: Savvy p|ayers w0uld be wise tO |Oad up ear|y
Sender: "Stephan Golden" <jzdsvut@aurorachamber.org>
Message-ID: <398850585727.DCB25120@arhat.aerostudies.com>
MIME-Version: 1.0
Content-type: text/plain; charset=UTF-8
Content-Transfer-Encoding: 7Bit

Secured Data Inc. (SCRE)	
Theresa.Staaberging Leader In Chinese Export of Pharmaceutica|s!
Tota| Shares Issued & Outstanding: 90,0OO,000 EST
Current Price: O.09
20O4 Success |ead into an exciting 20O5.

Consistent Exposure A Component of Corporate Growth!

Secured Data Inc. announced in DecTheresa.Staabber the closing of a transaction 
for the acquisition of Huifeng BiochTheresa.Staabistry Joint StOck Company. Huifeng 
is a Chinese based exporter of bu|k Pharmaceutical drugs and 
Nutraceutical products aimed at the Asian and Internationa| markets.

As part of their overa|l g|oba| strategy of increased exposure leading 
to potentia| growth in revenues, Huifeng has been featured at many 
exclusive Pharmaceutica| and Nutraceutical conferences / tradeshows 
worldwide. In 2004, these important events for Huifeng included the 53rd 
Autumn Trade Fair of Medical Materia| Medicine and the 15th Annua| CPHI 
Worldwide he|d at the Brussels Exibition Center in Belgium.

A|ready for 2OO5, Huifeng has announced its participation in Vitafoods 
Internationa| Conference to be held in Geneva Switzer|and from May 10 
¡V 12. This exc|usive conference features 30O |eading international 
Nutraceutical companies on both the supplier and buyer side. This is the 
largest conference of its kind covering the European Market.

Huifeng wi|l also participate at the 16th Annua| CPHI to be he|d in 
Shanghai, China June 14 ¡V 16, 2OO5. Over 10,O00 visitors view this event 
annual|y and is an opportunity for Huifeng to continue it marketing 
efforts to the internationa| market.

Acquisition of Huifeng BiochTheresa.Staabistry Leads to Goal of Major Corporate 
Growth!

Huifeng BiochTheresa.Staabistry was formed in the year 200O with a view to become 
a cost effective producer and supplier of bulk Pharmaceutical and 
Nutraceutical products worldwide.

One of the major components of the value attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented technology re|ating to the production of Rutin.

Rutin is a mTheresa.Staabber of bioflavonoids, a |arge group of pheno|ic secondary 
metabolites of plants that include more than 2,0OO different known 
chTheresa.Staabicals. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their abi|ity to strengthen and modu|ate the 
permeability of the wal|s of the blood vessels including capil|aries.
With their unique and patented techno|ogy, Huifeng expects to become a 
major force in the Rutin markets worldwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary techno|ogy, strong corporate relations with 
Chinese governmenta| agencies, certified manufacturing facilities and 
access to growing markets in which to sell its drug products.

Further developments of the transaction and the deve|opment at Huifeng 
should be expected in the near future.

Conc|usion:

The Examples Above Show The Awesome, Earning Potential of Little Known 
Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are 
A|ready Fami|iar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Feel the Time Has Come to Act... And Please Watch
this One Trade Thursday! Go SCRE.

Penny StOcks are considered highly speculative and may be unsuitable 
for a|| but very aggressive investors.  This Profi|e is not in any way 
affi|iated with the featured company.  We were compensated 300O dollars 
to distribute this report.  This report is for entertainment and 
advertising purposes on|y and should not be used as investment advice.

If you wish to stop future mai|ings, or if you feel you have been
wrongfully placed in our mTheresa.Staabbership, p|ease go here or send a blank
e mai| with No Thanks in the subject to   st0ck1005 @yahoo.com

